Global Tuberculosis Drugs Market 2011-2015

NEW YORK, Nov. 12, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p01027204/Global-Tuberculosis-Drugs-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

TechNavio's analysts forecast the Global Tuberculosis Drugs market to grow at a CAGR of 6.75 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the outbreak of TB-HIV co-infections. The Global Tuberculosis Drugs market has also been witnessing the trend of increased focus on TB vaccine development. However, insufficient demand in developed countries could pose a challenge to the growth of this market.

TechNavio's report, the Global Tuberculosis Drugs market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Tuberculosis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Eli Lilly and Co. GlaxoSmithKline plc. Pfizer Inc. and Sanofi SA.

What will the market size be in 2015 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

01. Executive Summary 02. Introduction 03. Market Coverage Key Offerings 04. Market Landscape 04.1 Global Tuberculosis Drugs Market Market Size 04.2 End-user Segmentation Classification of Tuberculosis Drugs 04.3 Drugs Used for the Treatment of TB First-line TB Drugs Second-line TB Drugs 04.4 Five Force Analysis 05. Rate of Incidence and Prevalence TB and HIV MDR-TB and XDR-TB Incidence Rate per 100,000 of the Population The 22 HBCs 06. Vendor Landscape 07. Buying Criteria 08. Global Tuberculosis Drug Pipeline Drugs in Discovery Stage of Development Drugs in Preclinical Stage of Development Drugs in Phase I Stage of Development Drugs in Phase II Stage of Development Drugs in Phase III Stage of Development 09. Global Tuberculosis Vaccine Pipeline 10. Market Growth Drivers 11. Drivers and Their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1 Eli Lilly and Co. Business Overview SWOT Analysis 15.2 Pfizer Inc. Business Overview SWOT Analysis 15.3 GlaxoSmithKline plc Business Overview SWOT Analysis 15.4 Sanofi SA Business Overview SWOT Analysis 16. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global Tuberculosis Drugs Market 2011-2015 (US$ million)

Exhibit 2: End-user Segmentation

Exhibit 3: Classification of Tuberculosis Drugs

Exhibit 4: Incidence Rate per 100,000 of the Population

Exhibit 5: The 22 HBCs

CONTACT
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker